Showing 1–10 of 10 results
-
Research |
Autologous stem cell transplantation for patients aged 60 years or older with refractory or relapsed classical Hodgkin’s lymphoma: a retrospective analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC)
- A Stamatoullas
- , P Brice
- , M S Gueye
- , S Mareschal
- , P Chevallier
- , R Bouabdallah
- , S Nguyenquoc
- , S Francois
- , P Turlure
- , P Ceballos
- , H Monjanel
- , J-H Bourhis
- , G Guillerm
- , M Mohty
- , P Biron
- , J Cornillon
- , K Belhadj
- , C Bonmati
- , M-S Dilhuydy
- , A Huynh
- , M Bernard
- , M-L Chrétien
- , R Peffault de Latour
- & H Tilly
Bone Marrow Transplantation 51 , 928–932 -
Research |
Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy
- J Gauthier
- , L Castagna
- , F Garnier
- , T Guillaume
- , G Socié
- , S Maury
- , N Maillard
- , R Tabrizi
- , T Marchand
- , J Malfuson
- , A Gac
- , E Gyan
- , M Mercier
- , Y Béguin
- , J Delage
- , P Turlure
- , A Marçais
- , S Nguyen
- , R Dulery
- , J Bay
- , A Huynh
- , E Daguindau
- , J Cornillon
- , C Régny
- , M Michallet
- , R Peffault de Latour
- , I Yakoub-Agha
- & D Blaise
Bone Marrow Transplantation 52 , 689–696 -
Research |
-
-
Research |
-
Research |
-
-
Research |
Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de Greffe de Moelle Osseuse et Thérapie Cellulaire and Eurocord
- S Nguyen
- , A Achour
- , L Souchet
- , S Vigouroux
- , P Chevallier
- , S Furst
- , A Sirvent
- , J-O Bay
- , G Socié
- , P Ceballos
- , A Huynh
- , J Cornillon
- , S Francois
- , F Legrand
- , I Yakoub-Agha
- , G Michel
- , N Maillard
- , G Margueritte
- , S Maury
- , M Uzunov
- , C-E Bulabois
- , M Michallet
- , L Clement
- , C Dauriac
- , K Bilger
- , J Lejeune
- , V Béziat
- , V Rocha
- , B Rio
- , S Chevret
- & V Vieillard
Bone Marrow Transplantation 52 , 1428–1435 -
-
Research |
High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial
- D Rossille
- , M Gressier
- , D Damotte
- , D Maucort-Boulch
- , C Pangault
- , G Semana
- , S Le Gouill
- , C Haioun
- , K Tarte
- , T Lamy
- , N Milpied
- , T Fest
- , G Damaj
- , A Clavert
- , A Al Jijakli
- , A Banos
- , J-L Dutel
- , E Deconinck
- , P Rodon
- , K Bouabdallah
- , P Soubeyran
- , B Choufi
- , A Maakaroun
- , O Tournilhac
- , J Fleury
- , R Gressin
- , H Maisonneuve
- , K Laribi
- , P Solal-Celigny
- , P Moreau
- , J-F Rossi
- , G Cartron
- , N Morineau
- , J L Harousseau
- , E Jourdan
- , M Alexis
- , F Dreyfus
- , V Delwail
- , J Cornillon
- , R Garidi
- , E Gyan
- , P Colombat
- & P Godemer
